The Green List has a zero-tolerance for illegal listings or prescription products.

June 27th Highlights

  • MediPharm Labs entered a research agreement with McMaster University - I feel an immense amount of satisfaction being able to share MediPharm Lab's most recent announcement - the collaboration between MPL and McMaster University. Over the coming years, I suspect it will become increasingly important for companies to validate the products they sell, via formal research pathways to ensure these products are high quality, safe AND efficacious. As more companies move towards this model, so to will the doctors and patients that adopt these products. I'm very pleased MediPharm Labs is on this path. The MediPharm team will work with various clinician groups at McMaster to assess the effectiveness of proprietary THC and CBD drug candidates for multiple indications including pain, insomnia associated with major depression, and uremic pruritus. Well done to our hard-working team for coordinating this agreement with McMaster University! 
  • When is it large, large enough? I read this week that Cannara completed its acquisition of TGOD's cultivation facility, adding a 1 million square foot licensed cultivation and manufacturing facility to its already 1,650,000 sq. ft indoor growing facilities across Canada and Quebec. In Australia, the group at Asterion announced their plans to build the world's largest medicinal cannabis facility in Toowoomba, a 40-hectare farm. There is no rational business case for occupying this much space for cannabis cultivation. My friend Matt Lamer said it perfectly “just ask Aurora, Canopy, Tilray, Green Organic Dutchman, etc, how their "world's largest cannabis greenhouses" went. Large indoor = large spend
  • The UK is the world’s largest exporter of medical cannabis, yet the nation’s own drug laws don’t reflect this position. However, a recently published paper released by Maple Tree Consultants and Mackrell.Solicitors are calling on the UK Government to review its restrictive approach to the country’s cannabis market, revealing the outdated laws and regulations that are hampering the growth of this multi-billion-pound industry. The paper noted that if red tape is reduced across the U.K., the medical cannabis market could be worth £2bn, create 97,000 new jobs, and transform access for the estimated 1.4 million individuals currently sourcing cannabis illegally for medical reasons, who are in desperate need of affordable cannabis medicine - article reference.

 

Opening the gates to hemp fed livestock in Australia

Medleaf and NGC land New Zealand flower shipment

Althea enters South African cannabis market

Hemp processing starts in Western Australia's south-west

Emyria files new patents for IBS treatment

Helius announces education program with DATAPHARM

Little Green Pharma secures deal to distribute medicinal cannabis products in Poland

Search